ECDC Portal > English > Publications
|
|
| | Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus | |
| Technical reports - 07 Dec 2012 |
Available as PDF in the following languages:
This document is free of charge. | ABSTRACT New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
ECDC’s updated risk assessment concludes that there is still no evidence of sustained person-to-person transmission; the current facts still point towards a zoonotic or environmental source with occasional transmission to exposed humans. | | |
|
|
|
|
|
|
|
|
|